Swirsky Douglas J 4
4 · MAXCYTE, INC. · Filed Mar 19, 2024
Insider Transaction Report
Form 4
MAXCYTE, INC.MXCT
Swirsky Douglas J
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2024-03-15+81,250→ 81,250 total - Award
Employee Stock Option (right to buy)
2024-03-15+225,000→ 225,000 totalExercise: $4.31Exp: 2034-03-14→ Common Stock (225,000 underlying)
Footnotes (2)
- [F1]These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Twenty-five percent (25%) of the RSUs shall vest on March 15, 2025, and the remainder shall vest in three (3) equal annual installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
- [F2]Twenty-five percent (25%) of the shares underlying this option shall vest on March 15, 2025, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.